Have to agree there...
The Nov 2017 update/preso 'flagged' the 'Pivotal Trial/Study' pathway for the MITCI trial for the first time then, which is why I suspected (and still do), that BMS obviously had/have done enough 'homework' (at that stage) on the 'logistics' of realising that outcome to flag it as such, they'd only be in a better position now, with more data, considering this data has a 10/03/18 cutoff...
Play it by ear I guess...
ML
Latest clinical trial results, page-9
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
